US20030021854A1 - Method of induction of apoptosis and inhibition of matrix metalloproteinases using antimicrobial metals - Google Patents

Method of induction of apoptosis and inhibition of matrix metalloproteinases using antimicrobial metals Download PDF

Info

Publication number
US20030021854A1
US20030021854A1 US10/131,568 US13156802A US2003021854A1 US 20030021854 A1 US20030021854 A1 US 20030021854A1 US 13156802 A US13156802 A US 13156802A US 2003021854 A1 US2003021854 A1 US 2003021854A1
Authority
US
United States
Prior art keywords
method
antimicrobial
set forth
nanocrystalline
antimicrobial metal
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US10/131,568
Inventor
Robert Burrell
John Wright
Kan Lam
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
NUCRYST PHARMACEUTICALS CORP
Original Assignee
NUCRYST PHARMACEUTICALS CORP
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to US28588401P priority Critical
Priority to US09/840,637 priority patent/US7008647B2/en
Application filed by NUCRYST PHARMACEUTICALS CORP filed Critical NUCRYST PHARMACEUTICALS CORP
Priority to US10/131,568 priority patent/US20030021854A1/en
Priority claimed from US10/159,587 external-priority patent/US7001617B2/en
Assigned to NUCRYST PHARMACEUTICALS CORP. reassignment NUCRYST PHARMACEUTICALS CORP. ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: LAM, KAN, WRIGHT, JOHN BARRYMORE, BURRELL, ROBERT EDWARD
Priority claimed from US10/277,298 external-priority patent/US6989157B2/en
Priority claimed from US10/277,358 external-priority patent/US20030185901A1/en
Priority claimed from US10/277,362 external-priority patent/US20030194444A1/en
Priority claimed from US10/277,320 external-priority patent/US20030206966A1/en
Publication of US20030021854A1 publication Critical patent/US20030021854A1/en
Priority claimed from US10/364,983 external-priority patent/US7078060B2/en
Priority claimed from US10/690,774 external-priority patent/US7255881B2/en
Priority claimed from US10/690,724 external-priority patent/US7427416B2/en
Priority claimed from US10/690,715 external-priority patent/US20040191329A1/en
Priority claimed from US10/770,132 external-priority patent/US7201925B2/en
Priority claimed from US11/250,516 external-priority patent/US20060115541A1/en
Application status is Abandoned legal-status Critical

Links